Markets:

Overview

News

Currencies

International

Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

12.36 -3.96 (-24.26%)

Streaming Delayed Price Updated: 1:54 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results

January 23, 2024

From QuidelOrtho Corporation

Via Business Wire

QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 22, 2023

From QuidelOrtho Corporation

Via Business Wire

QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

December 20, 2023

From QuidelOrtho Corporation

Via Business Wire

Analyst Expectations for QuidelOrtho's Future ↗

November 02, 2023

Via Benzinga

Where QuidelOrtho Stands With Analysts ↗

September 19, 2023

Via Benzinga

QuidelOrtho's Return on Invested Capital Overview ↗

May 11, 2023

Via Benzinga

QuidelOrtho: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

QuidelOrtho to Participate in the Evercore ISI Conference

November 16, 2023

From QuidelOrtho Corporation

Via Business Wire

Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report ↗

November 16, 2023

QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm.

Via Benzinga

QuidelOrtho Reports Third Quarter 2023 Financial Results

November 01, 2023

From QuidelOrtho Corporation

Via Business Wire

Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: Analyst ↗

October 12, 2023

QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,

Via Benzinga

Why QuidelOrtho Stock Popped by 5% on Friday ↗

April 15, 2023

It looks like the company's first quarter is going to please investors greatly.

Via The Motley Fool

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023

October 12, 2023

From QuidelOrtho Corporation

Via Business Wire

QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA

September 21, 2023

From QuidelOrtho Corporation

Via Business Wire

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 28, 2023

From QuidelOrtho Corporation

Via Business Wire

Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why ↗

August 15, 2023

Raymond James analyst Andrew Cooper reiterates Strong Buy on QuidelOrtho Corporation (NASDAQ: QDEL),

Via Benzinga

QuidelOrtho Reports Second Quarter 2023 Financial Results

August 08, 2023

From QuidelOrtho Corporation

Via Business Wire

QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row

July 25, 2023

From QuidelOrtho Corporation

Via Business Wire

QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings

July 25, 2023

From QuidelOrtho Corporation

Via Business Wire

QuidelOrtho to Report Second Quarter 2023 Financial Results

July 18, 2023

From QuidelOrtho Corporation

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 06, 2023

Via Benzinga

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference

May 23, 2023

From QuidelOrtho Corporation

Via Business Wire

Something Happened In Biotech Last Week ↗

May 08, 2023

Biotech stocks were more constructive last week with some sharp moves up.

Via Talk Markets

QuidelOrtho Reports First Quarter 2023 Financial Results

May 03, 2023

From QuidelOrtho Corporation

Via Business Wire

Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗

May 01, 2023

A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

April 24, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 20, 2023

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.